We could not find any results for:
Make sure your spelling is correct or try broadening your search.
IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for...
IBA et l'Institut Jules Bordet piloteront le projet IHI Accelerate.EU pour créer une chaîne de valeur complète pour l'Astate-211 Une initiative de 16 millions d'euros pour établir...
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 1er octobre 2024, 18:00...
IBA - Regulated Information (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, October 1st, 2024 06:00 Summary of the notification...
IBA Reports Half Year 2024 Results GROUP REVENUES UP 21.9% ACCELERATED BACKLOG CONVERSION IN PROTON THERAPY AND OTHER ACCELERATORS STRONG GROSS MARGIN IMPROVEMENT AND BREAKEVEN REBIT...
IBA publie ses résultats du premier semestre 2024 REVENUS DU GROUPE EN HAUSSE DE 21,9% ACCELERATION DE LA CONVERSION DU CARNET DE COMMANDES EN PROTONTHÉRAPIE ET AUTRES ACCELERATEURS FORTE...
IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Agreement further strengthens the long-term relationship between IBA and the...
IBA conclut un accord avec University of Pennsylvania Health System pour deux solutions de protonthérapie Proteus®ONE Un accord dans la continuité du partenariat à long terme entre IBA et...
IBA - Information réglementée (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 1er août 2024, 18 :00 Résumé de...
IBA - Regulated Information (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, August 1st, 2024 06:00 Summary of the notification IBA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.56 | -4.01146131805 | 13.96 | 14.5 | 13.32 | 26439 | 14.01646255 | DE |
4 | 0.04 | 0.299401197605 | 13.36 | 15.14 | 13.02 | 30502 | 14.35100951 | DE |
12 | 1.48 | 12.4161073826 | 11.92 | 15.14 | 10.7 | 26652 | 13.09204248 | DE |
26 | 0.7 | 5.51181102362 | 12.7 | 15.14 | 10.7 | 24675 | 13.12387453 | DE |
52 | 4.2 | 45.652173913 | 9.2 | 15.14 | 9.13 | 31732 | 11.98799484 | DE |
156 | -3.6 | -21.1764705882 | 17 | 19.28 | 8.26 | 24696 | 13.57098951 | DE |
260 | -0.8 | -5.6338028169 | 14.2 | 20.45 | 6.01 | 29069 | 12.87080874 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions